Clinical Trial Update: Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on phase 2 and phase 3 testing of continuous hemodialysis with an enhanced middle molecule clearance membrane for septic shock; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: Fresenius Medical Care France | Conditions: Septic Shock | Phase 2, Phase 3 | Status: COMPLETED